# Belgium Export Playbook for Europe

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks regional export playbook

Compare buyer markets, access conditions, and calculated product opportunities in Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.

## Navigation

- [Yugalinks home](https://www.yugalinks.com/)
- [Trade data](https://www.yugalinks.com/trade/)
- [Open country workspace](https://www.yugalinks.com/app/countries)
- [Data sources](https://www.yugalinks.com/data-sources)
- [Methodology](https://www.yugalinks.com/methodology)

## Overview

- Exporter: Belgium (BEL)
- Region: Europe
- Latest trade year: 2024
- Buyer markets: 24
- Calculated three-year opportunity: $923.9B
- Reported FTA markets: 21
- Average reported distance: 1,024 km
- Average business entry indicator: 10 days

## Market comparison

| Market | ISO3 | Opportunity | Products | FTA | Distance | Entry days | Top product |
| --- | --- | ---: | ---: | --- | ---: | ---: | --- |
| Germany | DEU | $177.7B | 49 | Reported | 197 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United Kingdom | GBR | $145.7B | 29 | Reported | 324 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| Netherlands | NLD | $108.7B | 27 | Reported | 173 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, Liechtenstein | CHE | $88.6B | 11 | Reported | 487 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| France | FRA | $71.7B | 23 | Reported | 262 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Italy | ITA | $70.9B | 15 | Reported | 1,175 km | 11 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Slovenia | SVN | $42.8B | 6 | Reported | 917 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| Russia | RUS | $39.2B | 8 | Not reported | 2,261 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| Spain | ESP | $36.9B | 14 | Reported | 1,317 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Poland | POL | $35.4B | 13 | Reported | 1,161 km | 37 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Czechia | CZE | $19.2B | 8 | Reported | 718 km | 25 | Telephones for cellular networks or for other wireless networks |
| Ireland | IRL | $15.5B | 5 | Reported | 776 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| Hungary | HUN | $14.4B | 6 | Reported | 1,130 km | 7 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Denmark | DNK | $12.6B | 4 | Reported | 767 km | 4 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Austria | AUT | $8.9B | 4 | Reported | 914 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| Sweden | SWE | $6.4B | 1 | Reported | 1,284 km | 8 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Romania | ROU | $5.6B | 2 | Not reported | 0 km | 0 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Finland | FIN | $4.7B | 1 | Reported | 1,652 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Slovakia | SVK | $4.7B | 2 | Reported | 971 km | 22 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Norway | NOR | $3.8B | 1 | Reported | 1,088 km | 4 | Vehicles: with only electric motor for propulsion |
| Greece | GRC | $3.0B | 2 | Reported | 2,089 km | 4 | Heterocyclic compounds: with oxygen hetero-atom(s) only, containing an unfused furan ring (whether or not hydrogenated) in the structure, n.e.c. in item no. 2932.1 |
| Lithuania | LTU | $3.0B | 1 | Reported | 1,469 km | 6 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Ukraine | UKR | $2.9B | 2 | Reported | 1,837 km | 7 | Ammunition: n.e.s. in chapter 93 |
| Belarus | BLR | $1.5B | 1 | Not reported | 1,602 km | 9 | Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc |

## Product and market opportunities

| Rank | Market | Product | Opportunity | Buyer growth | Current share |
| ---: | --- | --- | ---: | ---: | ---: |
| 1 | Switzerland, Liechtenstein (CHE) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.4B | +12.3% | +0.6% |
| 2 | United Kingdom (GBR) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $26.1B | +15.3% | +0.1% |
| 3 | Germany (DEU) | HS 850760 - Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.7B | +19.2% | +0.1% |
| 4 | United Kingdom (GBR) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $19.2B | +16.1% | +0.3% |
| 5 | Netherlands (NLD) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $17.5B | +6.5% | +1.6% |
| 6 | Switzerland, Liechtenstein (CHE) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $17.1B | +12.8% | +0.2% |
| 7 | Switzerland, Liechtenstein (CHE) | HS 710813 - Metals: gold, semi-manufactured | $16.9B | +14.3% | +1.0% |
| 8 | United Kingdom (GBR) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 9 | Italy (ITA) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $13.0B | +5.3% | +0.0% |
| 10 | Russia (RUS) | HS 870323 - Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 11 | Italy (ITA) | HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.8B | +29.0% | +0.0% |
| 12 | Slovenia (SVN) | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.3B | +34.8% | +0.0% |
| 13 | Germany (DEU) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $11.0B | +4.2% | +24.1% |
| 14 | Italy (ITA) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $10.9B | +7.2% | +0.0% |
| 15 | Slovenia (SVN) | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 16 | Poland (POL) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.9B | +8.1% | +0.0% |
| 17 | United Kingdom (GBR) | HS 870380 - Vehicles: with only electric motor for propulsion | $9.7B | +40.0% | +1.9% |
| 18 | Slovenia (SVN) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.2% |
| 19 | Germany (DEU) | HS 851712 - Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.2% |
| 20 | Germany (DEU) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.0B | +4.4% | +0.0% |

## Sector opportunities

| Sector | Products | Reported buyer imports | Opportunity | Average growth |
| --- | ---: | ---: | ---: | ---: |
| HS2 27 - HS2 sector 27 | 35 | $403.4B | $202.6B | +14.8% |
| HS2 87 - HS2 sector 87 | 42 | $235.3B | $130.5B | +20.5% |
| HS2 85 - HS2 sector 85 | 34 | $194.5B | $122.9B | +13.5% |
| HS2 30 - HS2 sector 30 | 27 | $227.6B | $104.2B | +13.4% |
| HS2 71 - HS2 sector 71 | 11 | $218.6B | $82.7B | +12.4% |
| HS2 84 - HS2 sector 84 | 21 | $102.4B | $72.3B | +9.3% |
| HS2 29 - HS2 sector 29 | 12 | $54.3B | $65.2B | +23.5% |
| HS2 00 - HS2 sector 00 | 13 | $125.3B | $43.2B | +7.8% |

## Frequently asked questions

### Should Belgium focus on Europe?

Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.

### What does calculated opportunity mean?

It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.

### How should exporters use this page?

Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, tariffs, standards, logistics, pricing, and competition before acting.

Yugalinks presents derived views for research and planning. [Read the full methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.